Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
A
Aplisens SA
WSE:APN
Aplisens SA
WSE:APN
Price:
18.9
PLN
2.72%
Market Closed
Market Cap:
zł210.5m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
A
|
Aplisens SA
WSE:APN
|
PL |
|
E
|
Eikon Therapeutics Inc
NASDAQ:EIKN
|
US |
|
Lithium Universe Ltd
OTC:LUVSF
|
AU |
|
Highwealth Construction Corp
TWSE:2542
|
TW |
|
S
|
Swiss Re AG
F:SR9
|
CH |
|
S
|
Stora Enso Oyj
XMUN:ENUA
|
FI |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is APN's stock price target?
Not Available
APN does not have any price targets made by Wall Street professionals.
What is the Revenue forecast for Aplisens SA?
Projected CAGR
5%
5%
Over the last 13 years, the compound annual growth rate for Revenue has been 5%. The projected CAGR for the next -7 years is 5%.
What is the Gross Profit forecast for Aplisens SA?
Projected CAGR
4%
4%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next -7 years is 4%.
What is the Operating Income forecast for Aplisens SA?
Projected CAGR
0%
0%
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next -7 years is 0%.
What is the Net Income forecast for Aplisens SA?
Projected CAGR
-1%
-1%
Over the last 13 years, the compound annual growth rate for Net Income has been 0%. The projected CAGR for the next -7 years is -1%.